AMEX Accepts Orgenics' Plan to Regain Compliance With Continued Listing Standards

ALACHUA, FL--(MARKET WIRE)--Jul 5, 2007 -- Oragenics, Inc. (AMEX:ONI - News), a biopharmaceutical company with a focus on infectious diseases and cancer, announced today that the American Stock Exchange (AMEX) has accepted the Company's plan to regain compliance with continued listing standards of AMEX. The Company's plan was submitted in response to a letter from AMEX which informed Oragenics that it was not in compliance with Section 1003(a)(i) of the AMEX Company Guide with shareholders' equity of less than $2,000,000 and losses from continuing operations and/or net losses in two out of its three most recent fiscal years.